EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Assessing treatment effect heterogeneity in the presence of missing effect modifier data in cluster-randomized trials

Bryan S Blette iD, Scott D Halpern, Fan Li iD, Michael O Harhay

Statistical Methods in Medical Research · 2024-05 · 33 (5) · 909-927

DOI: 10.1177/09622802241242323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistical Methods in Medical Research, online erschienen am 03.04.2024. Verfasst von Bryan S Blette und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Bayes Theorem. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, Patient-Centered Outcomes Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding whether and how treatment effects vary across subgroups is crucial to inform clinical practice and recommendations. Accordingly, the assessment of heterogeneous treatment effects based on pre-specified potential effect modifiers has become a common goal in modern randomized trials. However, when one or more potential effect modifiers are missing, complete-case analysis may lead to bias and under-coverage. While statistical methods for handling missing data have been proposed and compared for individually randomized trials with missing effect modifier data, few guidelines exist for the cluster-randomized setting, where intracluster correlations in the effect modifiers, outcomes, or even missingness mechanisms may introduce further threats to accurate assessment of heterogeneous treatment effect. In this article, the performance of several missing data methods are compared through a simulation study of cluster-randomized trials with continuous outcome and missing binary effect modifier data, and further illustrated using real data from the Work, Family, and Health Study. Our results suggest that multilevel multiple imputation and Bayesian multilevel multiple imputation have better performance than other available methods, and that Bayesian multilevel multiple imputation has lower bias and closer to nominal coverage than standard multilevel multiple imputation when there are model specification or compatibility issues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicBayes TheoremHumansCluster AnalysisData Interpretation, StatisticalBiasModels, StatisticalTreatment OutcomeComputer SimulationTreatment Effect Heterogeneity

Stichwörter der Autor:innen

Bayesian inferencecluster randomized trialsheterogeneous treatment effectsmissing datamultilevel multiple imputation

Autor:innen und Institutionen

  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Clinical Trials Methods and Outcomes Lab, PAIR (Palliative and Advanced Illness Research) Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
  • Center for Methods in Implementation and Prevention Science, Yale University, New Haven, CT, USA.

ORCID-Profile: Bryan S Blette, Fan Li

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • Patient-Centered Outcomes Research Institute
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Blette, B. S., Halpern, S. D., Li, F., & Harhay, M. O. (2024). Assessing treatment effect heterogeneity in the presence of missing effect modifier data in cluster-randomized trials. Statistical Methods in Medical Research, 33(5), 909-927. https://doi.org/10.1177/09622802241242323

Vancouver

Blette BS, Halpern SD, Li F, Harhay MO. Assessing treatment effect heterogeneity in the presence of missing effect modifier data in cluster-randomized trials. Statistical Methods in Medical Research. 2024;33(5):909-927. doi:10.1177/09622802241242323

BibTeX
@article{Blette2024,
  author = {Blette, Bryan S and Halpern, Scott D and Li, Fan and Harhay, Michael O},
  title = {Assessing treatment effect heterogeneity in the presence of missing effect modifier data in cluster-randomized trials},
  journal = {Statistical Methods in Medical Research},
  year = {2024},
  volume = {33},
  number = {5},
  pages = {909--927},
  doi = {10.1177/09622802241242323}
}
Kostenlos starten →